Comparison between donor-specific transfusions with conventional immunosuppression and triple therapy including cyclosporine in living related donor kidney transplantation.
Arbelaez
M
M
Transplant Group, University of Antioquia School of Medicine, Medellin, Colombia.
Mejia
G
G
Henao
J E
JE
Garcia
A
A
Arango
J L
JL
Velasquez
A
A
Restrepo
J
J
Garcia
L F
LF
D000206:Actuarial Analysis; D000293:Adolescent; D000328:Adult; D001379:Azathioprine / Q000008:administration & dosage*; D001803:Blood Transfusion; D002648:Child; D016572:Cyclosporine / Q000008:administration & dosage*; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000276:immunology / Q000401:mortality* / Q000517:prevention & control; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology / Q000401:mortality*; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000276:immunology / Q000401:mortality* / Q000517:prevention & control; D011239:Prednisolone / Q000008:administration & dosage*; D015996:Survival Rate; D014019:Tissue Donors
D016572:Cyclosporine; D011239:Prednisolone; D001379:Azathioprine